Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikhil Gupte

Showing results (101-110 of 136) with videos related to

Pageof 14
Sort By:
Frontiers in Tuberculosis|April 30, 2025
Clinical and laboratory risk factors for pulmonary tuberculosis recurrence in three pooled Indian cohortsSonya Krishnan, Nikhil Gupte, Mandar Paradkar, et al.
BMC Medicine|September 25, 2018
Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control studyRupak Shivakoti, Nikhil Gupte, Srikanth Tripathy, et al.
Plos One|August 2, 2018
Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden settingPadmapriyadarsini Chandrasekaran, Vidya Mave, Kannan Thiruvengadam, et al.
The Journal of Infectious Diseases|December 2, 2015
Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained SettingsRupak Shivakoti, Wei-Teng Yang, Sima Berendes, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 4, 2019
MAL adaptor (TIRAP) S180L polymorphism and severity of disease among tuberculosis patientsRajagopalan Saranathan, Pattabiraman Sathyamurthi, Kannan Thiruvengadam, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 4, 2016
Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy InitiationJyoti S Mathad, Nikhil Gupte, Ashwin Balagopal, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 8, 2017
Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort StudyMark W Tenforde, Ashish Yadav, David W Dowdy, et al.
The Journal of Infectious Diseases|December 5, 2019
Transcriptomic Profiles of Confirmed Pediatric Tuberculosis Patients and Household Contacts Identifies Active Tuberculosis, Infection, and Treatment Response Among Indian ChildrenJeffrey A Tornheim, Anil K Madugundu, Mandar Paradkar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2022
Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS TrialMandar S Paradkar, Bella Devaleenal D, Tisungane Mvalo, et al.
Plos One|February 27, 2015
C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settingsMark W Tenforde, Nikhil Gupte, David W Dowdy, et al.
Pageof 14

Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
Frontiers in Tuberculosis|April 30, 2025
Clinical and laboratory risk factors for pulmonary tuberculosis recurrence in three pooled Indian cohortsSonya Krishnan, Nikhil Gupte, Mandar Paradkar, et al.
BMC Medicine|September 25, 2018
Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control studyRupak Shivakoti, Nikhil Gupte, Srikanth Tripathy, et al.
Plos One|August 2, 2018
Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden settingPadmapriyadarsini Chandrasekaran, Vidya Mave, Kannan Thiruvengadam, et al.
The Journal of Infectious Diseases|December 2, 2015
Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained SettingsRupak Shivakoti, Wei-Teng Yang, Sima Berendes, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 4, 2019
MAL adaptor (TIRAP) S180L polymorphism and severity of disease among tuberculosis patientsRajagopalan Saranathan, Pattabiraman Sathyamurthi, Kannan Thiruvengadam, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 4, 2016
Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy InitiationJyoti S Mathad, Nikhil Gupte, Ashwin Balagopal, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 8, 2017
Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort StudyMark W Tenforde, Ashish Yadav, David W Dowdy, et al.
The Journal of Infectious Diseases|December 5, 2019
Transcriptomic Profiles of Confirmed Pediatric Tuberculosis Patients and Household Contacts Identifies Active Tuberculosis, Infection, and Treatment Response Among Indian ChildrenJeffrey A Tornheim, Anil K Madugundu, Mandar Paradkar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2022
Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS TrialMandar S Paradkar, Bella Devaleenal D, Tisungane Mvalo, et al.
Plos One|February 27, 2015
C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settingsMark W Tenforde, Nikhil Gupte, David W Dowdy, et al.
Pageof 14